Literature DB >> 943424

Serum creatine phosphokinase concentrations after intramuscular chlordiazepoxide and its solvent.

D J Greenblatt, R I Shader, J Koch-Weser.   

Abstract

Serum creatine phosphokinase (CPK) concentrations were determined in healthy volunteers for the first 48 hours after intramuscular injection of 50 mg chlordiazepoxide hydrochloride or of its solvent alone. Intramuscular injection of both the drug solution and its solvent was painful and caused CPK elevations. The CPK rise due to the drug solution was 33 per cent higher than that due to the solvent alone, but the difference was not significant. The pH of the solvent preparation is low and it contains high concentrations of propylene glycol. The pain and muscle damage due to injection of the solvent could be due to its acidity and its high osmolarity. Problems associated with intramuscular injections of water-insoluble drugs are not resolved by the use of such solvent preparations.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 943424     DOI: 10.1002/j.1552-4604.1976.tb02392.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  4 in total

Review 1.  Adult sedation: oral, rectal, IM, IV.

Authors:  J A Giovannitti; L D Trapp
Journal:  Anesth Prog       Date:  1991 Jul-Oct

Review 2.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

3.  Absorption of oral and intramuscular chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; S M MacLeod; E M Sellers; K Franke; H G Giles
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; S M MacLeod; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.